Human monoclonal anti-human IL-17A antibody (Secukinumab)

Authors

Institutions

Publication Details

Journal
Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology
Published
2024-12-19
DOI
https://doi.org/10.3388/jspaci.38.474
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human monoclonal anti-human IL-17A antibody (Secukinumab)

Nami Okamoto
Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology
Autoimmune Bullous Skin Diseases
article

Human monoclonal anti-human IL-17A antibody (Secukinumab)

Nami Okamoto
article en

Abstract

No abstract available for this paper.
Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical ImmunologyVol. 38(5)
Osaka Rosai Hospital (JP), Osaka University of Pharmaceutical Sciences (JP)
Openalex Percentile: Top 62%
Autoimmune Bullous Skin Diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Human monoclonal anti-human IL-17A antibody (Secukinumab) — Nami Okamoto · Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology (2024) | TGRS Research Map | TGRS